Representatives from the National Cancer Institute and the Office of Medical Applications of Research of the NIH convened at a three-day conference to assess available scientific research related to colorectal cancer, including a discussion on the importance of screening in detecting colorectal cancer, according to the release.
At the meeting, Laura Seeff, MD, of the Centers for Disease Control and Prevention presented the CDC’s ongoing research into the medical community’s capacity for colorectal cancer screening citing ASCs role in providing this important service, according to the release. More than 40 percent of Medicare colonoscopies are provided in the ASC setting.
“On behalf of the Ambulatory Surgery Center Advocacy Committee, I commend NIH for recognizing the high quality, safe and cost-effective colorectal cancer screening services offered by ASCs throughout the U.S.,” Arnold Levy, MD, a practicing gastroenterology physician and president and CEO of a 55-physician gastroenterology group in Washington, D.C., said in the release. “ASCs are committed to achieving the 50 percent reduction in colorectal cancer death rates highlighted in the report and the ASC Advocacy Committee looks forward to working with key stakeholders to achieve this goal. ASCs are proud to be part of the solution to improve patient access to colorectal screening services.”
Learn more about the ASC Association.
